Home / Recalls / Wise Pharmacy / D-1569-2019

D-1569-2019 Class II Terminated

Recalled by Wise Pharmacy — Littleton, CO

FDA drug recall D-1569-2019 was initiated by Wise Pharmacy on July 22, 2019 and is designated Class II. Reason for recall: Lack of Processing Controls The recall status is terminated (terminated February 3, 2020). Affected quantity: 27 vials.

Recall Details

Product Type: Drugs
Report Date: August 7, 2019
Initiation Date: July 22, 2019
Termination Date: February 3, 2020
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 27 vials

Product Description

Dexamethasone Sodium Phosphate PF 24 mg/mL Injection, Refrigerate, Single Use Vial, 1 mL vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.

Reason for Recall

Lack of Processing Controls

Distribution Pattern

CO, TX, WY

Code Information

Lots #: 5506N, Exp 9/21/2019; 7180N, Exp 12/29/2019

Other recalls by Wise Pharmacy

D-1572-2019 Class II — Papaverine/Phentolamine 30 mg/1 mg/mL Injectable, 2.5 mL Vial, Rx only, Compound (July 22, 2019)
D-1571-2019 Class II — Tobramycin Irrigation 80 mg/1000 mL Solution, 1000 mL Container, Refrigerate, Na (July 22, 2019)
D-1576-2019 Class II — Papaverine/Phentolamine/Alprostadil 30 mg/2 mg/50 mcg/mL Injectable, 2.5 mL Vial (July 22, 2019)
D-1573-2019 Class II — Papaverine/Phentolamine/Alprostadil 30 mg/0.2 mg/10 mcg/mL Injectable, 2.5 mL Vi (July 22, 2019)
D-1574-2019 Class II — Papaverine/Phentolamine/Alprostadil - 30 mg/1 mg/10 mcg/mL Injectable, 2.5 mL Vi (July 22, 2019)
D-1568-2019 Class II — Alprostadil 100 mcg/mL Injectable, 2.5 mL vial, Rx only, Compounded by Wise Phar (July 22, 2019)
D-1567-2019 Class II — Acetylcysteine 2% Otic Drop, 15 mL bottle, Rx only, Refrigerate, Compounded by W (July 22, 2019)
D-1570-2019 Class II — Gentamicin (GU) Irrigation 240 mg/500 mL Solution, 250 mL Container, Shake well (July 22, 2019)
D-1575-2019 Class II — Papaverine/Phentolamine/Alprostadil 30 mg/2 mg/30 mcg/mL Injectable, 2.5 mL Vial (July 22, 2019)
D-1577-2019 Class II — Papaverine/Phentolamine/Alprostadil/Atropine 30 mg/2 mg/50 mcg/0.15 mg/mL Inject (July 22, 2019)